Artisan Partners Trims Stake in RxSight, Inc.

Institutional investor reduces position in medical tech firm by over 22%

Published on Mar. 3, 2026

Got story updates? Submit your updates here. ›

Artisan Partners Limited Partnership, a major institutional investor, has reduced its stake in RxSight, Inc. (NASDAQ:RXST) by 22.1% in the third quarter, according to a recent SEC filing. RxSight is a medical technology company focused on developing and commercializing advanced intraocular lens (IOL) systems for cataract surgery and lens replacement procedures.

Why it matters

The reduction in Artisan Partners' position in RxSight could signal a shift in investor sentiment around the company and its flagship Light Adjustable Lens (LAL) product. As a prominent institutional investor, Artisan Partners' trading activity is closely watched by the market and may influence the stock price and perceptions of RxSight's future prospects.

The details

According to the filing, Artisan Partners Limited Partnership owned 1,753,683 shares of RxSight at the end of the third quarter, down from 2,252,544 shares held in the prior quarter. The sale of 498,861 shares represents a 22.1% reduction in the firm's position. RxSight's stock price has fluctuated in recent quarters, trading between $6.32 and $29.00 over the past year.

  • Artisan Partners reduced its RxSight stake in the 3rd quarter of 2026.

The players

Artisan Partners Limited Partnership

A major institutional investor that has reduced its stake in medical technology company RxSight, Inc.

RxSight, Inc.

A medical technology company focused on developing and commercializing advanced intraocular lens (IOL) systems for cataract surgery and lens replacement procedures.

Got photos? Submit your photos here. ›

The takeaway

Artisan Partners' reduction in its RxSight position could signal broader market uncertainty around the company's prospects, though the reasons behind the move are not entirely clear. Investors will likely watch closely to see if other major institutional holders follow suit or maintain their positions in the medical tech firm.